Cargando…

Human Chorionic Gonadotropin monotherapy for the treatment of hypogonadal symptoms in men with total testosterone > 300 ng/dL

PURPOSE: The 2018 American Urological Association guidelines on the Evaluation and Management of Testosterone Deficiency recommended that 300 ng/dL be used as the threshold for prescribing testosterone replacement therapy (TRT). However, it is not uncommon for men to present with signs and symptoms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madhusoodanan, Vinayak, Patel, Premal, Lima, Thiago Fernandes Negris, Gondokusumo, Jabez, Lo, Eric, Thirumavalavan, Nannan, Lipshultz, Larry I., Ramasamy, Ranjith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Urologia 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844348/ https://www.ncbi.nlm.nih.gov/pubmed/31408289 http://dx.doi.org/10.1590/S1677-5538.IBJU.2019.0132

Ejemplares similares

Efficacy and Safety of Human Chorionic Gonadotropin Monotherapy for Men With Hypogonadal Symptoms and Normal Testosterone
por: Zucker, Isaac, et al.
Publicado: (2022)

The Safety of Human Chorionic Gonadotropin Monotherapy Among Men With Previous Exogenous Testosterone Use
por: Rainer, Quinn, et al.
Publicado: (2022)

Hypogonadism and renal failure: An update
por: Thirumavalavan, Nannan, et al.
Publicado: (2015)

Testosterone versus clomiphene citrate in managing symptoms of hypogonadism in men
por: Dadhich, Pranav, et al.
Publicado: (2017)

Role of testosterone to estradiol ratio in predicting the efficacy of recombinant human chorionic gonadotropin and testosterone treatment in male hypogonadism
por: Çelik, Mehmet, et al.
Publicado: (2021)

Patient Attitudes Toward Testicular Prosthesis Placement After Orchiectomy
por: Srivatsav, Ashwin, et al.
Publicado: (2019)

Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men
por: Lee, John Alden, et al.
Publicado: (2018)

Effect of microsurgical varicocelectomy on semen parameters, serum, and intratesticular testosterone levels
por: Lima, Thiago Fernandes Negris, et al.
Publicado: (2020)

Preserving fertility in the hypogonadal patient: an update
por: Ramasamy, Ranjith, et al.
Publicado: (2015)

Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study
por: Chen, Yin-Wei, et al.
Publicado: (2019)

OR25-6 In Men on Testosterone Therapy, Baseline Testosterone Level of <264 ng/dL is Associated with Greater Improvement in Body Composition, While Level of ≥264 ng/dL Favors Improvement in Metabolic Profile
por: Aguirre, Lina, et al.
Publicado: (2022)

Human chorionic gonadotropin therapy in hypogonadic severe-oligozoospermic men and its effect on semen parameters
por: Andrabi, Syed Waseem, et al.
Publicado: (2022)

Efficacy and safety of human chorionic gonadotropin combined with human menopausal gonadotropin and a gonadotropin-releasing hormone pump for male adolescents with congenital hypogonadotropic hypogonadism
por: Liu, Ying, et al.
Publicado: (2021)

Penile Growth in Response to Human Chorionic Gonadotropin (hCG) Treatment in Patients with Idiopathic Hypogonadotrophic Hypogonadism
por: Kim, Sun-Ouck, et al.
Publicado: (2011)

Low Testosterone in Adolescents & Young Adults
por: Cohen, Jordan, et al.
Publicado: (2020)

The Effects of Fetal Gender on Serum Human Chorionic Gonadotropin and Testosterone in Normotensive and Preeclamptic Pregnancies
por: Lorzadeh, Nahid, et al.
Publicado: (2012)

Corrigendum: Low Testosterone in Adolescents & Young Adults
por: Cohen, Jordan, et al.
Publicado: (2020)

Risks of testosterone therapy in elderly men
por: Ramasamy, Ranjith, et al.
Publicado: (2014)

Evaluating the Combination of Human Chorionic Gonadotropin and Clomiphene Citrate in Treatment of Male Hypogonadotropic Hypogonadism: A Prospective Study
por: Trinh, The Son, et al.
Publicado: (2021)

Hypogonadism induced by surgical stress and brain trauma is reversed by human chorionic gonadotropin in male rats: A potential therapy for surgical and TBI‐induced hypogonadism?
por: Geddes, Rastafa I., et al.
Publicado: (2021)

Retracted: The Effects of Fetal Gender on Serum Human Chorionic Gonadotropin and Testosterone in Normotensive and Preeclamptic Pregnancies
por: Journal of Pregnancy,
Publicado: (2013)

Association of Leptin with Total and Free Testosterone: Results from the National Health and Nutrition Examination Surveys
por: Lima, Thiago Fernandes Negris, et al.
Publicado: (2020)

Treatment situation of male hypogonadotropic hypogonadism in pediatrics and proposal of testosterone and gonadotropins replacement therapy protocols
por: Sato, Naoko, et al.
Publicado: (2015)

Experimental Production of Gynecomastia with Chorionic Gonadotropin
por: Klatskin, Gerald, et al.
Publicado: (1952)

Chorionic gonadotropin and uterine dialogue in the primate
por: Cameo, Paula, et al.
Publicado: (2004)

IMMUNOHISTOCHEMICAL LOCALIZATION OF HUMAN CHORIONIC GONADOTROPIN
por: Midgley, A. R., et al.
Publicado: (1962)

Human Chorionic Gonadotropin and Breast Cancer
por: Schüler-Toprak, Susanne, et al.
Publicado: (2017)

Production of Mare Chorionic Girdle Organoids That Secrete Equine Chorionic Gonadotropin
por: Thompson, Riley E., et al.
Publicado: (2023)

Impact of Short-Acting vs Long-Acting Testosterone Therapy on Intratesticular Testosterone Using Data From Two Open-Label Randomized Clinical Trials of Testosterone Pellets, Injections, and Intranasal Gel in Hypogonadal Men
por: Kresch, Eliyahu, et al.
Publicado: (2021)

Fertility Rates of Ewes Treated with Medroxyprogesterone and Injected with Equine Chorionic Gonadotropin plus Human Chorionic Gonadotropin in Anoestrous Season
por: Santos, I. W., et al.
Publicado: (2010)

The relationship between the variants in the 5′-untranslated regions of equine chorionic gonadotropin genes and serum equine chorionic gonadotropin levels
por: Liu, ShuQin, et al.
Publicado: (2017)

Testosterone replacement in male hypogonadism
por: Kalra, Sanjay, et al.
Publicado: (2010)

Single‐dose pharmacokinetic study comparing the pharmacokinetics of recombinant human chorionic gonadotropin in healthy Japanese and Caucasian women and recombinant human chorionic gonadotropin and urinary human chorionic gonadotropin in healthy Japanese women
por: Bagchus, Wilhelmina, et al.
Publicado: (2017)

Current Routine Testosterone Immunoassays Are Unsuitable for Lowering the General Castration Cutoff Recommendation to <0.7 nmol/l (20 ng/dl)
por: van Rossum, Huub H., et al.
Publicado: (2023)

Human Chorionic Gonadotropin: The Pregnancy Hormone and More
por: Theofanakis, Charalampos, et al.
Publicado: (2017)

Human Chorionic Gonadotropin and Early Embryogenesis: Review
por: d’Hauterive, Sophie Perrier, et al.
Publicado: (2022)

U-shaped Association Between Prevalence of Secondary Hypogonadism and Body Mass Index: A Retrospective Analysis of Men with Testosterone Deficiency
por: Gurayah, Aaron A., et al.
Publicado: (2023)

Dual trigger with gonadotropin-releasing hormone and human chorionic gonadotropin for poor responders
por: Eser, Ahmet, et al.
Publicado: (2018)

Late-onset hypogonadism: beyond testosterone
por: Foresta, Carlo, et al.
Publicado: (2015)

Efficacy and safety outcomes of a compounded testosterone pellet versus a branded testosterone pellet in men with testosterone deficiency: a single-center, open-label, randomized trial
por: Kresch, Eliyahu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0rcb6dqot1pdj401206jg9ounh